IDIA — Idorsia Share News
0.000.00%
Last trade - 00:00- CH₣1.60bn
- CH₣2.74bn
- CH₣220.58m
Brief: Idorsia Appoints Roland Wandeler As CEO
Brief: Idorsia Enters Senior Secured Term Loan Of Up To CHF 250 Million
Swiss stocks - Factors to watch on May 15
Switzerland's Idorsia posts Q1 loss as high QUVIVIQ sales more than offset by costs, lack of one-time gain
Brief: Idorsia Financial Guidance For 2026 Unchanged
Swiss stocks - Factors to watch on April 28
Brief: Idorsia Reports Daridorexant Results In A Phase 2 Study In Children With Insomnia Disorder
Brief: Idorsia Says CEO Srishti Will Step Down From Her Role
Switzerland's Idorsia 2025 revenue rises, loss narrows on strong QUVIVIQ sales
Brief: Idorsia FY EBIT CHF -33 Million
Brief: Idorsia Announces Exclusive License And Supply Agreement With Ems S.A.
Swiss stocks - Factors to watch on January 6
Brief: Idorsia Posts Phase 3 Study Results Of Daridorexant
Brief: Idorsia’S Jeraygo (Aprocitentan) Approved In Canada For The Treatment Of Resistant Hypertension
Brief: Idorsia-New Hypertension Publication Underscores Aprocitentan’S Potential In Managing Hypertension Patients With Ckd
Europe Research Roundup: BMW, EQT, Nestle
Swiss stocks - Factors to watch on October 30
Brief: Idorsia 9M EBIT CHF 23 Million
Brief: Idorsia Completes Upsized Offering Of Shares